
Parbendazole
CAS No. 14255-87-9
Parbendazole( SKF 29044 )
Catalog No. M20537 CAS No. 14255-87-9
Parbendazole is a potent inhibitor of microtubule assembly(EC50 : 8.79?nM).Parbendazole is a carbamate ester-amine. It finds applications in control or treatment of nematode infestations.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
10MG | 41 | In Stock |
![]() ![]() |
25MG | 64 | In Stock |
![]() ![]() |
50MG | 88 | In Stock |
![]() ![]() |
100MG | 155 | In Stock |
![]() ![]() |
200MG | 231 | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameParbendazole
-
NoteResearch use only, not for human use.
-
Brief DescriptionParbendazole is a potent inhibitor of microtubule assembly(EC50 : 8.79?nM).Parbendazole is a carbamate ester-amine. It finds applications in control or treatment of nematode infestations.
-
DescriptionParbendazole is a potent inhibitor of microtubule assembly(EC50 : 8.79?nM).Parbendazole is a carbamate ester-amine. It finds applications in control or treatment of nematode infestations.
-
In VitroParbendazole is a tubulin destabilizer, with an EC50 of 530?nM, and can induce DNA damage. Parbendazole (2-10 μM) inhibits the assembly of microtubules dose-dependently, with an IC50 of 3 μM. Parbendazole (2-20 μM)-treated cells show an complete absence of microtubules in Vero cells. Parbendazole (up to 10 μM) inhibits the growth of CLd-AXE myxamoebae. Parbendazole (2-5 μM) potently inhibits tubulin purified from the wild-type myxamoebae.
-
In Vivo——
-
SynonymsSKF 29044
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetMicrotubule/Tubulin
-
Recptormicrotubule
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number14255-87-9
-
Formula Weight247.29
-
Molecular FormulaC13H17N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:4 mg/mL (16.18 mM)
-
SMILESCCCCc1ccc2nc(NC(=O)OC)[nH]c2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lo Y C Senese S France B et al. Computational Cell Cycle Profiling of Cancer Cells for Prioritizing FDA-Approved Drugs with Repurposing Potential[J]. Scientific Reports 2017 7(1):11261.
molnova catalog



related products
-
Auristatin F
Auristatin F is an effective inhibitor of microtubule and vascular damaging agent. Auristatin F can be used in antibody-drug conjugates.
-
Plinabulin
Plinabulin (NPI-2358) is a vascular disrupting agent (VDA) against tubulin-depolymerizing with IC50 of 9.8~18 nM in tumor cells. Phase 1/2.
-
Sovilnesib
Sovilnesib is a kinesin-like protein KIF18A inhibitor (WO2020132648). Sovilnesib can be used for the research of cancer.